Cabaletta Bio Statistics

Total Valuation

Cabaletta Bio has a market cap or net worth of $356.76 million. The enterprise value is $141.09 million.

Market Cap	356.76M
Enterprise Value	141.09M

Important Dates

The next estimated earnings date is Thursday, August 8, 2024, before market open.

Earnings Date	Aug 8, 2024
Ex-Dividend Date	n/a

Share Statistics

Cabaletta Bio has 48.28 million shares outstanding. The number of shares has increased by 53.92% in one year.

Shares Outstanding	48.28M
Shares Change (YoY)	+53.92%
Shares Change (QoQ)	+12.58%
Owned by Insiders (%)	3.14%
Owned by Institutions (%)	112.70%
Float	43.45M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.61
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.66, with a Debt / Equity ratio of 0.04.

Current Ratio	12.66
Quick Ratio	n/a
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -38.80% and return on invested capital (ROIC) is -37.29%.

Return on Equity (ROE)	-38.80%
Return on Assets (ROA)	-36.10%
Return on Capital (ROIC)	-37.29%
Revenue Per Employee	n/a
Profits Per Employee	-$651,424
Employee Count	118
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -39.87% in the last 52 weeks. The beta is 2.47, so Cabaletta Bio's price volatility has been higher than the market average.

Beta (5Y)	2.47
52-Week Price Change	-39.87%
50-Day Moving Average	10.80
200-Day Moving Average	16.66
Relative Strength Index (RSI)	32.58
Average Volume (20 Days)	1,773,592

Short Selling Information

The latest short interest is 9.45 million, so 19.58% of the outstanding shares have been sold short.

Short Interest	9.45M
Short Previous Month	9.47M
Short % of Shares Out	19.58%
Short % of Float	21.75%
Short Ratio (days to cover)	8.58

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-85.74M
Pretax Income	-76.87M
Net Income	-76.87M
EBITDA	-72.37M
EBIT	-76.87M
Earnings Per Share (EPS)	-$1.72

Full Income Statement

Balance Sheet

The company has $223.85 million in cash and $8.17 million in debt, giving a net cash position of $215.68 million or $4.47 per share.

Cash & Cash Equivalents	223.85M
Total Debt	8.17M
Net Cash	215.68M
Net Cash Per Share	$4.47
Equity (Book Value)	221.72M
Book Value Per Share	4.59
Working Capital	209.51M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$64.93 million and capital expenditures -$1.12 million, giving a free cash flow of -$66.05 million.

Operating Cash Flow	-64.93M
Capital Expenditures	-1.12M
Free Cash Flow	-66.05M
FCF Per Share	-$1.37

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Cabaletta Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-53.92%
Shareholder Yield	-53.92%
Earnings Yield	-21.55%
FCF Yield	-18.51%

Analyst Forecast

The average price target for Cabaletta Bio is $35.78, which is 384.17% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$35.78
Price Target Difference	384.17%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3